Senior insider sale
CEO and President at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$118.1K
7.50K shares
What this filing means
STENGONE CARMINE N. plans to sell 7.50K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $118.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2026ACC: 0001950047-26-001156
DirectorOfficer· CEO and President
Since Feb 2026
7.50K
Shares to sell
$118.1K
Approx. market value
7.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
2/11/2026
7.50KTotal acquired7.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Exercise of Stock Options Cash | 7.50K | — |
| Total | 7.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.50K
Market value
$118.1K
2/11/2026
Total
Units
7.50K
Value
$118.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/11/2026 | 7.50K | $118.1K | NASDAQ | Planned |
| Total | 7.50K | $118.1K | ||